首页> 外文OA文献 >The use of real-time PCR technique in the detection of novel protein 4.2 gene mutations that coexist with thalassaemia alpha in a single patient
【2h】

The use of real-time PCR technique in the detection of novel protein 4.2 gene mutations that coexist with thalassaemia alpha in a single patient

机译:实时PCR技术在单例患者中检测与地中海贫血α共存的新型4.2蛋白基因突变的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

α-Thalassaemia is a very rare disease in Northern Europe in contrast to hereditary spherocytosis that is associated with red blood cell membrane defects. We report here α-thalassaemia case who was also found to bear the erythrocyte membrane protein 4.2 gene mutations. mRNA relative quantification of red cell membrane protein genes in a Polish patient with α-thalassaemia trait indicated EPB42 as the gene that could also be involved in anaemia pathogenesis. Sequencing revealed the presence of two novel mutations in the protein 4.2 gene: a G1701A genetic change that predicts an alanine to threonine at position 567 of the protein (A567T) and a T→A substitution that is located at position +6 of the donor splice site of intron 2 (IVS2nt+6T>A). This is the sixth variant of the erythrocyte membrane protein 4.2 gene mutations identified outside the Japanese population.
机译:与遗传性血球增多症(与红细胞膜缺陷有关)相比,α-地中海贫血在北欧是一种非常罕见的疾病。我们在这里报告的α型地中海贫血病例也被发现带有红细胞膜蛋白4.2基因突变。波兰患有α地中海贫血性状的患者中红细胞膜蛋白基因的mRNA相对定量表明,EPB42是可能与贫血发病机制有关的基因。测序揭示了蛋白质4.2基因中存在两个新突变:一个G1701A遗传变化,预测该蛋白质(A567T)位置567处的丙氨酸变为苏氨酸,以及位于供体剪接+6处的T→A取代内含子2的位点(IVS2nt + 6T> A)。这是在日本人群之外发现的红细胞膜蛋白4.2基因突变的第六种变异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号